Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-22-004775

Options or other derivatives

  • Chief Executive Officer acquired 28,405 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Vounatsos Michel Chief Executive Officer 2022-02-10 Grant or award · Restricted Stock Unit +28,405 28,405 D
Loading xslF345X03/form4.xml…